Yisheng Lai

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Regulatory T Cells

Computed Tomography

Top Venues

Journal of medicinal chemistry

Journal of enzyme inhibition and medicinal chemistry

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Qingyun Wei, Kun Yao, Jie Yang, Qian Zhou, Pengyu Liu, Jiao Chen, Haipeng Liu, Yisheng Lai, Peng Cao
Structure-Based Drug Design of Novel Triaminotriazine Derivatives as Orally Bioavailable IDH2 R140Q Inhibitors with High Selectivity and Reduced hERG Inhibitory Activity for the Treatment of Acute Myeloid Leukemia. Journal of medicinal chemistry (2023)
Wen Liu, Yi Zou, Kaiming Li, Haiqing Zhong, Longbo Yu, Shushan Ge, Yisheng Lai, Xianchi Dong, Qiang Xu, Wenjie Guo
Apo-Form Selective Inhibition of IDO for Tumor Immunotherapy. Journal of immunology (Baltimore, Md. : 1950) 209 (1) (2022)
Yiqiang OuYang, Jian Gao, Lei Zhao, Junfeng Lu, Haiqing Zhong, Hua Tang, Shuanglong Jin, Lu Yue, Yuezhen Li, Wenjie Guo, Qiang Xu, Yisheng Lai
Design, Synthesis, and Evaluation of o-(Biphenyl-3-ylmethoxy)nitrophenyl Derivatives as PD-1/PD-L1 Inhibitors with Potent Anticancer Efficacy In Vivo. Journal of medicinal chemistry 64 (11) (2021)
Shushan Ge, Haiqing Zhong, Xuewei Ma, Yingbo Zheng, Yi Zou, Fang Wang, Yan Wang, Yue Hu, Yuezhen Li, Wen Liu, Wenjie Guo, Qiang Xu, Yisheng Lai
Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)